Trial Outcomes & Findings for Moderate Versus Deep Procedural Sedation With Propofol in the Emergency Department (NCT NCT02404610)
NCT ID: NCT02404610
Last Updated: 2021-11-30
Results Overview
adverse respiratory events measured using capnography, pulse oximetry, and airway maneuvers performed during the sedation procedure
COMPLETED
PHASE4
107 participants
From start of procedure until the patient has returned to baseline mental status after the conclusion of the sedation procedure, an expected average time of 30 minutes
2021-11-30
Participant Flow
Participant milestones
| Measure |
Moderate Procedural Sedation
Subjects will undergo procedural sedation for an indicated urgent medical procedure with a target sedation level of moderate sedation. Moderate procedural sedation is a specific term referring to procedural sedation with a target depth of moderate.
Moderate Procedural Sedation with a sedative medication.: procedural sedation with a target sedation depth of moderate. Moderate sedation is not a drug specific intervention, it is achieved with the use of a sedative or a combination of sedations and opioids.
propofol
|
Deep Procedural Sedation
Subjects will undergo procedural sedation for an indicated urgent medical procedure with a target sedation level of deep sedation. Deep procedural sedation is a specific term referring to procedural sedation with a target depth of deep.
Deep Procedural Sedation with a sedative medication.: procedural sedation with a target sedation depth of deep. Deep sedation is not a drug specific intervention, it is achieved with the use of a sedative or a combination of sedations and opioids.
propofol
|
|---|---|---|
|
Overall Study
STARTED
|
54
|
53
|
|
Overall Study
COMPLETED
|
54
|
53
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Moderate Procedural Sedation
n=54 Participants
Subjects will undergo procedural sedation for an indicated urgent medical procedure with a target sedation level of moderate sedation. Moderate procedural sedation is a specific term referring to procedural sedation with a target depth of moderate.
Moderate Procedural Sedation with a sedative medication.: procedural sedation with a target sedation depth of moderate. Moderate sedation is not a drug specific intervention, it is achieved with the use of a sedative or a combination of sedations and opioids.
propofol
|
Deep Procedural Sedation
n=53 Participants
Subjects will undergo procedural sedation for an indicated urgent medical procedure with a target sedation level of deep sedation. Deep procedural sedation is a specific term referring to procedural sedation with a target depth of deep.
Deep Procedural Sedation with a sedative medication.: procedural sedation with a target sedation depth of deep. Deep sedation is not a drug specific intervention, it is achieved with the use of a sedative or a combination of sedations and opioids.
propofol
|
Total
n=107 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=54 Participants
|
0 Participants
n=53 Participants
|
0 Participants
n=107 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
51 Participants
n=54 Participants
|
49 Participants
n=53 Participants
|
100 Participants
n=107 Participants
|
|
Age, Categorical
>=65 years
|
3 Participants
n=54 Participants
|
4 Participants
n=53 Participants
|
7 Participants
n=107 Participants
|
|
Age, Continuous
|
41.5 years
n=54 Participants
|
39 years
n=53 Participants
|
40 years
n=107 Participants
|
|
Sex: Female, Male
Female
|
30 Participants
n=54 Participants
|
25 Participants
n=53 Participants
|
55 Participants
n=107 Participants
|
|
Sex: Female, Male
Male
|
24 Participants
n=54 Participants
|
28 Participants
n=53 Participants
|
52 Participants
n=107 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
54 participants
n=54 Participants
|
53 participants
n=53 Participants
|
107 participants
n=107 Participants
|
PRIMARY outcome
Timeframe: From start of procedure until the patient has returned to baseline mental status after the conclusion of the sedation procedure, an expected average time of 30 minutesPopulation: patients undergoing procedural sedation in the ED
adverse respiratory events measured using capnography, pulse oximetry, and airway maneuvers performed during the sedation procedure
Outcome measures
| Measure |
Moderate Procedural Sedation
n=54 Participants
Subjects will undergo procedural sedation for an indicated urgent medical procedure with a target sedation level of moderate sedation. Moderate procedural sedation is a specific term referring to procedural sedation with a target depth of moderate.
Moderate Procedural Sedation with a sedative medication.: procedural sedation with a target sedation depth of moderate. Moderate sedation is not a drug specific intervention, it is achieved with the use of a sedative or a combination of sedations and opioids.
propofol
|
Deep Procedural Sedation
n=53 Participants
Subjects will undergo procedural sedation for an indicated urgent medical procedure with a target sedation level of deep sedation. Deep procedural sedation is a specific term referring to procedural sedation with a target depth of deep.
Deep Procedural Sedation with a sedative medication.: procedural sedation with a target sedation depth of deep. Deep sedation is not a drug specific intervention, it is achieved with the use of a sedative or a combination of sedations and opioids.
propofol
|
|---|---|---|
|
Patients With Clinical Signs of Respiratory Depression or Sub Clinical Respiratory Depressions Measured by Capnography and Pulse Oximetry.
|
22 Participants
|
21 Participants
|
Adverse Events
Moderate Procedural Sedation
Deep Procedural Sedation
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Moderate Procedural Sedation
n=54 participants at risk
Subjects will undergo procedural sedation for an indicated urgent medical procedure with a target sedation level of moderate sedation. Moderate procedural sedation is a specific term referring to procedural sedation with a target depth of moderate.
Moderate Procedural Sedation with a sedative medication.: procedural sedation with a target sedation depth of moderate. Moderate sedation is not a drug specific intervention, it is achieved with the use of a sedative or a combination of sedations and opioids.
propofol
|
Deep Procedural Sedation
n=53 participants at risk
Subjects will undergo procedural sedation for an indicated urgent medical procedure with a target sedation level of deep sedation. Deep procedural sedation is a specific term referring to procedural sedation with a target depth of deep.
Deep Procedural Sedation with a sedative medication.: procedural sedation with a target sedation depth of deep. Deep sedation is not a drug specific intervention, it is achieved with the use of a sedative or a combination of sedations and opioids.
propofol
|
|---|---|---|
|
Respiratory, thoracic and mediastinal disorders
adverse respiratory event
|
38.9%
21/54 • Number of events 30 • From 3 minutes prior to the start of the sedation encounter up until the time the patient regained their baseline mental status up to 24 hours.
adverse respiratory events were defined as the occurrence of one or more clinical features of respiratory depression, including an oxygen saturation \<91%, a change in baseline ETCO2 of \>10 mm HG, or a loss of ETCO2 waveform, associated with the occurrence of any supportive airway maneuvers, including the use of a bag-valve mask apparatus, airway repositioning, the use of an oral or nasal airway to improve ventilation, or any stimulation to induce respirations.
|
45.3%
24/53 • Number of events 40 • From 3 minutes prior to the start of the sedation encounter up until the time the patient regained their baseline mental status up to 24 hours.
adverse respiratory events were defined as the occurrence of one or more clinical features of respiratory depression, including an oxygen saturation \<91%, a change in baseline ETCO2 of \>10 mm HG, or a loss of ETCO2 waveform, associated with the occurrence of any supportive airway maneuvers, including the use of a bag-valve mask apparatus, airway repositioning, the use of an oral or nasal airway to improve ventilation, or any stimulation to induce respirations.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place